![François Ravenelle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
François Ravenelle
Fondateur chez
Inversago Pharma, Inc.
Profil
François Ravenelle was the founder of Inversago Pharma, Inc. which was founded in 2015, where he held the title of Chief Executive Officer & Director.
He previously worked as Director-Business Development at Labopharm, Inc. from 2002 to 2008, Director-Pharmaceutical Development at Theratechnologies, Inc., and Director-Pharmaceutical Development at Verlyx Pharma, Inc. from 2011 to 2013.
Dr. Ravenelle earned a doctorate degree from McGill University in 2002.
Postes actifs de François Ravenelle
| Sociétés | Poste | Début |
|---|---|---|
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment | Fondateur | 01/01/2015 |
Anciens postes connus de François Ravenelle
| Sociétés | Poste | Fin |
|---|---|---|
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Corporate Officer/Principal | 01/01/2008 |
| THERATECHNOLOGIES INC. | Corporate Officer/Principal | - |
Verlyx Pharma, Inc.
 Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic pharmaceutical products | Corporate Officer/Principal | - |
Formation de François Ravenelle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Theratechnologies, Inc.
 Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic pharmaceutical products | Health Technology |
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment | Health Technology |
Choisissez Zonebourse 
